Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NXRT - US65341D1028 - REIT

30.02 USD
-0.08 (-0.27%)
Last: 12/31/2025, 10:12:39 AM
Fundamental Rating

2

NXRT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. NXRT may be in some trouble as it scores bad on both profitability and health. NXRT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NXRT has reported negative net income.
In the past year NXRT had a positive cash flow from operations.
Of the past 5 years NXRT 4 years were profitable.
Each year in the past 5 years NXRT had a positive operating cash flow.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

NXRT has a Return On Assets of -2.64%. This is amonst the worse of the industry: NXRT underperforms 90.00% of its industry peers.
The Return On Equity of NXRT (-15.06%) is worse than 90.00% of its industry peers.
NXRT has a Return On Invested Capital of 1.26%. This is in the lower half of the industry: NXRT underperforms 70.00% of its industry peers.
NXRT had an Average Return On Invested Capital over the past 3 years of 1.37%. This is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROIC 1.26%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of NXRT has declined.
Looking at the Operating Margin, with a value of 11.35%, NXRT is doing worse than 70.00% of the companies in the same industry.
NXRT's Operating Margin has improved in the last couple of years.
NXRT has a Gross Margin of 63.29%. This is amongst the best in the industry. NXRT outperforms 90.00% of its industry peers.
NXRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.35%
PM (TTM) N/A
GM 63.29%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

NXRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NXRT has been reduced compared to 1 year ago.
The number of shares outstanding for NXRT has been increased compared to 5 years ago.
Compared to 1 year ago, NXRT has a worse debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

NXRT has an Altman-Z score of 0.41. This is a bad value and indicates that NXRT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NXRT (0.41) is worse than 65.00% of its industry peers.
The Debt to FCF ratio of NXRT is 33.86, which is on the high side as it means it would take NXRT, 33.86 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NXRT (33.86) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.55 is on the high side and indicates that NXRT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.55, NXRT is doing worse than 85.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Altman-Z 0.41
ROIC/WACC0.16
WACC7.75%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.72 indicates that NXRT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, NXRT is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
NXRT has a Quick Ratio of 0.72. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
NXRT has a Quick ratio of 0.72. This is in the better half of the industry: NXRT outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

The earnings per share for NXRT have decreased strongly by -209.25% in the last year.
Measured over the past years, NXRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -65.41% on average per year.
The Revenue has decreased by -4.46% in the past year.
Measured over the past years, NXRT shows a small growth in Revenue. The Revenue has been growing by 7.48% on average per year.
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%

3.2 Future

NXRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -301.87% yearly.
NXRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.23% yearly.
EPS Next Y-6291.4%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
EPS Next 5YN/A
Revenue Next Year-2.72%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.47%
Revenue Next 5Y1.23%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

65.00% of the companies in the same industry are more expensive than NXRT, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than NXRT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.56
EV/EBITDA 17.72
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

NXRT's earnings are expected to decrease with -301.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%

6

5. Dividend

5.1 Amount

NXRT has a Yearly Dividend Yield of 7.28%, which is a nice return.
Compared to an average industry Dividend Yield of 11.48, NXRT pays a bit more dividend than its industry peers.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 7.28%

5.2 History

On average, the dividend of NXRT grows each year by 10.88%, which is quite nice.
NXRT has paid a dividend for at least 10 years, which is a reliable track record.
NXRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-109.03%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (12/31/2025, 10:12:39 AM)

30.02

-0.08 (-0.27%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners76.9%
Inst Owner Change2.46%
Ins Owners13.3%
Ins Owner Change-1.14%
Market Cap761.31M
Revenue(TTM)252.99M
Net Income(TTM)-48.65M
Analysts72.86
Price Target34.34 (14.39%)
Short Float %2.8%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 7.28%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-109.03%
Div Incr Years9
Div Non Decr Years9
Ex-Date12-15 2025-12-15 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.4%
Min EPS beat(2)12.33%
Max EPS beat(2)18.46%
EPS beat(4)3
Avg EPS beat(4)-34.15%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)6
Avg EPS beat(8)63.98%
EPS beat(12)7
Avg EPS beat(12)18.82%
EPS beat(16)9
Avg EPS beat(16)53.78%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.27%
Revenue beat(12)3
Avg Revenue beat(12)1.74%
Revenue beat(16)5
Avg Revenue beat(16)1.32%
PT rev (1m)-2.42%
PT rev (3m)-5.16%
EPS NQ rev (1m)4.9%
EPS NQ rev (3m)-5.7%
EPS NY rev (1m)1.83%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.01
P/FCF 17.56
P/OCF 9.07
P/B 2.36
P/tB 2.36
EV/EBITDA 17.72
EPS(TTM)-1.89
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)1.71
FCFY5.69%
OCF(TTM)3.31
OCFY11.02%
SpS9.98
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROCE 1.59%
ROIC 1.26%
ROICexc 1.27%
ROICexgc 1.28%
OM 11.35%
PM (TTM) N/A
GM 63.29%
FCFM 17.14%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexgc growth 3Y22.72%
ROICexgc growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Debt/EBITDA 11.72
Cap/Depr 42.01%
Cap/Sales 16.04%
Interest Coverage 0.32
Cash Conversion 66.98%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 0.41
F-Score4
WACC7.75%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
EPS Next Y-6291.4%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%
Revenue Next Year-2.72%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.47%
Revenue Next 5Y1.23%
EBIT growth 1Y-15.85%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18718%
EBIT Next 3Y489.77%
EBIT Next 5Y288.05%
FCF growth 1Y206.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.06%
OCF growth 3Y0.14%
OCF growth 5Y7.45%

NEXPOINT RESIDENTIAL / NXRT FAQ

Can you provide the ChartMill fundamental rating for NEXPOINT RESIDENTIAL?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


What is the valuation status of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


How financially healthy is NEXPOINT RESIDENTIAL?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 2 / 10.